Novartis is the official first-in-category corporate pharmaceutical partner of the National Football League (NFL).
The partnership aims to empower football fans everywhere to make proactive decisions about their health, better understand screening guidelines and create a playbook for a healthier future.
“At the heart of this first-of-its-kind partnership is the ambition to educate and mobilize communities to detect cancer and other diseases early, broadening health solutions beyond medicine,” says Victor Bultó, President US of Novartis, in a news release. “With its nationwide fan base and demonstrated commitment to health advocacy, the NFL is a powerful partner for igniting critical health conversations at an unmatched scale. Together, Novartis and the NFL are working toward leveling the playing field against serious health conditions, empowering every fan to proactively manage their health.”
Within the first year, the joint effort will focus on strengthening the support of the NFL’s Crucial Catch initiative alongside the American Cancer Society (ACS). Crucial Catch promotes cancer awareness, early detection and risk reduction. To learn more about Crucial Catch, visit NFL.com/CrucialCatch.
“At the NFL, we’re always looking for new ways to provide the highest level of care to our players, including through collaboration with experts across the medical field. Novartis is the ideal partner to help us in this mission due to their unparalleled expertise in innovative medicines and their dedication to improving health outcomes,” adds Chief Medical Officer at the NFL, Dr. Allen Sills. “At our upcoming Medical Summit, and beyond, we’ll work with Novartis in leveraging our combined strengths to advance health initiatives and make a lasting impact at the league and in communities across the country.”
Novartis will also serve as the league’s presenting partner for the upcoming Health and Safety Summit, Pro Football Hall of Fame Game and Hall of Fame Class Presentation at NFL Honors, and the company will support My Cause My Cleats through storytelling around players and the causes most important to them. Novartis will also activate at the 2025 NFL Draft, Super Bowl LX and other special events throughout the season.
“We’re thrilled to welcome Novartis as our first-ever corporate partner across the pharmaceutical category,” says Senior Vice President, Sponsorship at the NFL Tracie Rodburg. “As we continue to strategically prioritize the health and wellness space, we look forward to working with Novartis. Together we will be able to make an impact in communities for our fans across the 2025 season and in the years ahead.”
